Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

FDA approves Marshall Edwards' IND for lead NADH oxidase inhibitor

Aug. 19, 2011

Phase II trial of Cell Therapeutics' Opaxio opens enrollment

Aug. 19, 2011

MAA accepted and NDA submitted for ridaforolimus

Aug. 19, 2011

Curis doses first patient in CUDC-101 head and neck cancer study

Aug. 19, 2011

Kinex Pharmaceuticals begins phase I trial of KX2-391 in AML

Aug. 19, 2011

FDA grants fast track status to DARA's KRN-5500

Aug. 19, 2011

New vitamin D analogues claimed

Aug. 19, 2011

Novel antitumor agents disclosed by Chinese and U.S. team

Aug. 19, 2011

New antitumor agents synthesized by Kyowa Hakko Kirin

Aug. 19, 2011

Dual FGF/VEGF pathway inhibitor shows promise in limiting tumor resistance to VEGF inhibition

Aug. 18, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...